ContractConfidentiality Disclosure Agreement • March 3rd, 2022
A model Confidentiality Disclosure Agreement (mCDA) template, for use during the early set-up of commercial contract research in NHS organisations
Confidentiality Disclosure AgreementConfidentiality Disclosure Agreement • November 9th, 2021
WHEREAS The Parties seek to enter this Agreement to protect information which is regarded as valuable and confidential from third parties to flourish further discussion and/or collaboration in accordance with this Agreement.
MODEL CONFIDENTIALITY DISCLOSURE AGREEMENT (mCDA)Confidentiality Disclosure Agreement • March 3rd, 2022 • England and Wales
The Company [as an independent contractor on behalf of the [insert Sponsor details] (the “Sponsor”)] is willing to disclose certain Confidential Information (as hereinafter defined) to the Recipient for the purpose of discussions relating to feasibility relating to evaluating whether or not the Recipient wishes to participate in the clinical trial entitled “[add protocol title]” with the protocol number “[insert protocol number]” (“Clinical Trial”); (the “Purpose”).
CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • August 25th, 2021
In connection with discussions on the Purpose, the Parties will provide each other with information which the Parties regards as confidential, and because of its confidentiality such information may have a certain value for the Party providing it.
This CONFIDENTIALITY-DISCLOSURE AGREEMENT is made by and betweenConfidentiality-Disclosure Agreement • August 25th, 2020 • Ontario
, 20 by the undersigned (“Recipient”) in favor of KSR International Inc. and its parent, subsidiaries and affiliated entities (“Protected Parties”).
Confidentiality Disclosure Agreement Evaluation panel [Name of initiative] [Name of the call]Confidentiality Disclosure Agreement • September 2nd, 2013
NIH SPARC DAT-CORE CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • November 30th, 2018 • District of Columbia
the Undersigned and the National Institutes of Health (NIH) (together “the Parties”) and is effective as of the date of signature below (the “Effective Date”). This Agreement must be executed by each individual prior to becoming a participating member of the SPARC Embargoed Data Sharing Group (“Participant”). A current list of all Participants will be readily accessible to all researchers funded by the NIH SPARC program (such researchers and their laboratories, “Consortium Members”).
CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • September 7th, 2016
You have expressed an interest in the above business in which we represent the SELLER and you have requested information to assess whether you wish to buy the business. You agree that:
CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • May 5th, 2020
This Confidentiality Disclosure Agreement (this “Agreement”), effective as of ______________, between Northwestern University (“Northwestern”), with a principal business address at 633 Clark Street, Evanston, IL 60208, and [legal name of entity] (“Receiving Party”), with a principal business address at [legal business address], shall govern the conditions of disclosure by Northwestern to Receiving Party and its employee, [please enter PI’s name] (“Investigator”), for the purpose of maintaining the confidential business and technical information of Northwestern.
CONFIDENTIALITY DISCLOSURE AGREEMENT Page 1 of 2Confidentiality Disclosure Agreement • June 4th, 2018 • Connecticut
This agreement is between Optimal Learning Alliances, LLC, (OLA) a Connecticut Limited Liability Company (having an office at 53 Laurel Lane, Columbia, Ct) and
CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • January 20th, 2012
CONFIDENTIALITY DISCLOSURE AGREEMENTConfidentiality Disclosure Agreement • January 25th, 2005
The Association of Black Cardiologists, Inc. (hereafter referred to as [ABC]) may bring to my attention various research studies from time to time to solicit my participation. I agree to keep confidential all study related information that might be presented to me for my review including but not limited to the Study protocol (hereinafter referred to as [the Confidential Information]).
